vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and TELEFLEX INC (TFX). Click either name above to swap in a different company.
TELEFLEX INC runs the higher net margin — 177.8% vs 2.7%, a 175.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -150.5%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-92.9M). Over the past eight quarters, TELEFLEX INC's revenue compounded faster (NaN% CAGR vs NaN%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with...
IRTC vs TFX — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $-401.9M |
| Net Profit | $5.6M | $-714.3M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | — |
| Net Margin | 2.7% | 177.8% |
| Revenue YoY | 27.1% | -150.5% |
| Net Profit YoY | 518.5% | -422.7% |
| EPS (diluted) | $0.18 | $-15.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $-401.9M | ||
| Q3 25 | $192.9M | $913.0M | ||
| Q2 25 | $186.7M | $780.9M | ||
| Q1 25 | $158.7M | $700.7M | ||
| Q4 24 | $164.3M | $795.4M | ||
| Q3 24 | $147.5M | $764.4M | ||
| Q2 24 | $148.0M | $749.7M | ||
| Q1 24 | $131.9M | $737.8M |
| Q4 25 | $5.6M | $-714.3M | ||
| Q3 25 | $-5.2M | $-408.9M | ||
| Q2 25 | $-14.2M | $122.6M | ||
| Q1 25 | $-30.7M | $95.0M | ||
| Q4 24 | $-1.3M | $-136.7M | ||
| Q3 24 | $-46.2M | $111.0M | ||
| Q2 24 | $-20.1M | $80.0M | ||
| Q1 24 | $-45.7M | $15.3M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | 49.5% | ||
| Q2 25 | 71.2% | 55.2% | ||
| Q1 25 | 68.8% | 55.6% | ||
| Q4 24 | 70.0% | 55.3% | ||
| Q3 24 | 68.8% | 56.3% | ||
| Q2 24 | 69.9% | 55.6% | ||
| Q1 24 | 66.3% | 56.4% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | -4.4% | -44.8% | ||
| Q2 25 | -10.0% | 19.9% | ||
| Q1 25 | -20.5% | 17.9% | ||
| Q4 24 | -2.5% | -13.9% | ||
| Q3 24 | -34.1% | 19.5% | ||
| Q2 24 | -15.5% | 15.6% | ||
| Q1 24 | -28.9% | -0.6% |
| Q4 25 | 2.7% | 177.8% | ||
| Q3 25 | -2.7% | -44.8% | ||
| Q2 25 | -7.6% | 15.7% | ||
| Q1 25 | -19.3% | 13.6% | ||
| Q4 24 | -0.8% | -17.2% | ||
| Q3 24 | -31.3% | 14.5% | ||
| Q2 24 | -13.6% | 10.7% | ||
| Q1 24 | -34.6% | 2.1% |
| Q4 25 | $0.18 | $-15.85 | ||
| Q3 25 | $-0.16 | $-9.24 | ||
| Q2 25 | $-0.44 | $2.77 | ||
| Q1 25 | $-0.97 | $2.07 | ||
| Q4 24 | $-0.03 | $-2.89 | ||
| Q3 24 | $-1.48 | $2.36 | ||
| Q2 24 | $-0.65 | $1.69 | ||
| Q1 24 | $-1.47 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $378.6M |
| Total DebtLower is stronger | — | $2.6B |
| Stockholders' EquityBook value | $152.7M | $3.1B |
| Total Assets | $1.0B | $6.9B |
| Debt / EquityLower = less leverage | — | 0.85× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $378.6M | ||
| Q3 25 | $565.2M | $354.0M | ||
| Q2 25 | $545.5M | $253.7M | ||
| Q1 25 | $520.6M | $284.1M | ||
| Q4 24 | $535.6M | $290.2M | ||
| Q3 24 | $522.0M | $243.2M | ||
| Q2 24 | $561.5M | $238.6M | ||
| Q1 24 | $569.1M | $237.4M |
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $152.7M | $3.1B | ||
| Q3 25 | $121.9M | $3.8B | ||
| Q2 25 | $103.7M | $4.2B | ||
| Q1 25 | $86.7M | $4.1B | ||
| Q4 24 | $90.9M | $4.3B | ||
| Q3 24 | $71.8M | $4.5B | ||
| Q2 24 | $99.2M | $4.6B | ||
| Q1 24 | $90.3M | $4.5B |
| Q4 25 | $1.0B | $6.9B | ||
| Q3 25 | $995.2M | $7.9B | ||
| Q2 25 | $964.0M | $7.4B | ||
| Q1 25 | $926.1M | $7.2B | ||
| Q4 24 | $931.4M | $7.1B | ||
| Q3 24 | $909.7M | $7.5B | ||
| Q2 24 | $919.2M | $7.4B | ||
| Q1 24 | $909.8M | $7.5B |
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $-92.3M |
| Free Cash FlowOCF − Capex | $14.5M | $-92.9M |
| FCF MarginFCF / Revenue | 6.9% | 23.1% |
| Capex IntensityCapex / Revenue | 5.6% | -0.2% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $1.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $-92.3M | ||
| Q3 25 | $34.9M | $107.8M | ||
| Q2 25 | $27.7M | $7.8M | ||
| Q1 25 | $-7.9M | $73.3M | ||
| Q4 24 | $19.2M | $202.6M | ||
| Q3 24 | $24.3M | $231.1M | ||
| Q2 24 | $11.8M | $91.7M | ||
| Q1 24 | $-52.0M | $112.8M |
| Q4 25 | $14.5M | $-92.9M | ||
| Q3 25 | $20.1M | $77.8M | ||
| Q2 25 | $17.3M | $-26.8M | ||
| Q1 25 | $-17.3M | $43.3M | ||
| Q4 24 | $12.4M | $170.6M | ||
| Q3 24 | $15.5M | $209.9M | ||
| Q2 24 | $3.4M | $56.9M | ||
| Q1 24 | $-61.8M | $74.4M |
| Q4 25 | 6.9% | 23.1% | ||
| Q3 25 | 10.4% | 8.5% | ||
| Q2 25 | 9.3% | -3.4% | ||
| Q1 25 | -10.9% | 6.2% | ||
| Q4 24 | 7.5% | 21.4% | ||
| Q3 24 | 10.5% | 27.5% | ||
| Q2 24 | 2.3% | 7.6% | ||
| Q1 24 | -46.8% | 10.1% |
| Q4 25 | 5.6% | -0.2% | ||
| Q3 25 | 7.7% | 3.3% | ||
| Q2 25 | 5.6% | 4.4% | ||
| Q1 25 | 5.9% | 4.3% | ||
| Q4 24 | 4.2% | 4.0% | ||
| Q3 24 | 6.0% | 2.8% | ||
| Q2 24 | 5.7% | 4.6% | ||
| Q1 24 | 7.4% | 5.2% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.08× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 7.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TFX
Segment breakdown not available.
